Company news

ANI Pharmaceuticals, Inc. news in 2019

ANI Pharmaceuticals, Inc.'s news releases, calls and decks from 2019, newest first.

View company

ANI Pharmaceuticals to Present at Evercore ISI 2nd Annual HealthCONx Conference

November 25, 2019

ANI Pharmaceuticals Reports Third Quarter Results

November 5, 2019

ANI Announces Plans to Launch Bretylium Tosylate Injection, USP 500mg/10ml (50mg/ml) for Ventricular Arrhythmias

October 30, 2019

ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter and Year-to-Date 2019 Financial Results

October 29, 2019

ANI Pharmaceuticals announces the launch of ANI Global Source, its contract development and manufacturing business

October 28, 2019

ANI Announces Positive Clinical Results from Cortrophin® Gel Cortisol Response Study

October 2, 2019

ANI Pharmaceuticals Announces Launch of Aspirin and Extended Release Dipyridamole Capsules, 25mg/200mg

October 1, 2019

ANI Pharmaceuticals Announces Launch of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL

September 10, 2019

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2019 Financial Results

July 30, 2019

ANI Pharmaceuticals Announces Launch of Ranitidine Capsules

June 24, 2019

ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml

June 19, 2019

ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc.

June 17, 2019

ANI Pharmaceuticals to Present at Raymond James Life Sciences and MedTech Conference

June 11, 2019

ANI Pharmaceuticals Schedules Conference Call to Discuss First Quarter 2019 Financial Results

May 1, 2019

ANI Pharmaceuticals Expands Injectable Portfolio with Distribution Agreement for FDA Approved Injectable Product

April 14, 2019

Decks in 2019